Historical record - last NADAC effective date: 6/22/2016
Product Information
CLOBEX 0.05% SPRAY is a brand product labeled by Galderma Laboratories, L.P., priced at $6.7863 per ML under NDC 00299384904. Its NADAC has been published 190 times since Nov 28, 2013.
FDA first approved this application on Oct 27, 2005. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the clobetasol propionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.05 g/mL
Manufacturer
Galderma Laboratories, L.P.NDC
00299384904
Classification
Brand
Dosage Form
SPRAY
Route
TOPICAL
Effective Date
6/22/2016
Active Ingredients
CLOBETASOL PROPIONATEApproval Type
New Drug (NDA)
FDA Application
NDA021835FDA Approved
10/27/2005
TE Code
AT
On Market Since
10/27/2005
Pharmacological Classes
Price Statistics
The NADAC for CLOBEX 0.05% SPRAY has been published 190 times since Nov 28, 2013, and over the history we have for it it has risen 75.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.7863 per ML |
|---|---|
| All-time high | $6.7863 (Jul 12, 2017) |
| All-time low | $3.8764 (Nov 28, 2013) |
| Median price | $5.9643 |
| Average price | $5.7952 |
| Largest weekly change | +10.0% (Jul 8, 2015) |
| Weeks tracked | 190 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+75.1%
Last surveyed Jul 12, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Galderma Laboratories, L.P. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clobetasol propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOBEX 0.05% SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for CLOBEX 0.05% SPRAY, manufactured by Galderma Laboratories, L.P., is $6.7863 per ML (NDC 00299384904), effective Jul 12, 2017.
How has the price of CLOBEX 0.05% SPRAY changed over time?
Over the history we have for it, the NADAC for CLOBEX 0.05% SPRAY has risen 75.1%. It has been tracked across 190 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLOBEX 0.05% SPRAY?
Since Nov 28, 2013, the NADAC for CLOBEX 0.05% SPRAY has ranged from a low of $3.8764 (Nov 28, 2013) to a high of $6.7863 (Jul 12, 2017), with a median of $5.9643 per ML.
Are there cheaper alternatives to CLOBEX 0.05% SPRAY?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOBETASOL PROP 0.05% SPRAY, is $0.2480 per ML — about 96% below CLOBEX 0.05% SPRAY.
Who manufactures CLOBEX 0.05% SPRAY?
CLOBEX 0.05% SPRAY (NDC 00299384904) is labeled by Galderma Laboratories, L.P., and CMS classifies it as a brand product.